Corona vaccine (Photo credits: PTI)
Copenhagen: The Danish Health Authority (Johnson & Johnson Vaccine)Johnson and johnson Vaccine) decided to separate it from its collective coronavirus vaccination program. Helen Proust, deputy director general of the Danish Health Authority, said in a statement on Monday, “Considering the current situation in Denmark, and the possible side effects in the form of severe blood clots in people after the vaccination of Kovid-19, We can’t take any more risks. ” Get the information of COVID-19 Vaccine Center near your home on WhatsApp, this is the complete process
“In the midst of an epidemic, this has been a difficult decision, especially after we have also stopped using the AstraZeneca vaccine.” According to the report of the news agency Xinhua, the European Medicines Agency (EMA) concluded that “soudifect cannot be ignored in view of the benefits”. The Authority’s decision concludes that there exists a possible link between rare but severe cases of blood clots (vaccine-induced immune thrombotic thrombocytopenia or VITT) and the Johnson & Johnson vaccine.
According to the statement, this decision will affect people in the age group of 20 to 39, who will now face delays of up to four weeks in vaccination. However, the authority also said that these are not an everlasting decision, whether the Johnson & Johnson vaccine can be used later.
On 14 April, Denmark imposed complete management on the AstraZeneca Kovid 19 vaccine. Pfizer, Biotech and Mordana vaccines are currently included in the country’s official vaccination program.
Nevertheless, Danish citizens still have the opportunity to choose both voluntarily and freely banned AstraZeneca and Johnson & Johnson Kovid 19 vaccines. The Danish Parliament supported the decision in a majority vote. Danish news agency Ritzau reported on Monday that alternative vaccination plans are expected to begin in May. According to the State Serum Institute (SSI), Denmark on Monday registered 762 new cases with no new deaths in the last 24 hours.